CD34 and acute kidney injury: Also, Ohtake et al. reported the effectiveness of G-CSF mobilized human CD34+ therapy in a mice experimental model of ischemic/reperfusion acute kidney injury (AKI), which drastically upgraded renal function and repaired loss of peritubular capillaries because of ischemic condition (Ohtake et al., 2018a).